Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 22.9B | 22.1B | 22.9B | 21.0B |
Cost of revenue | 15.9B | 14.7B | 15.3B | 15.0B |
Gross profit | 7.0B | 7.4B | 7.5B | 6.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 4.2B | 3.6B | 3.4B | 3.3B |
Operating income | 2.8B | 3.8B | 4.2B | 2.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 174.7M | 179.7M | 185.1M | 189.5M |
Other income expense | — | — | — | — |
Pretax income | 3.9B | 4.6B | 4.9B | 3.5B |
Tax provision | 1.0B | 1.2B | 1.2B | 868.7M |
Net income | 3.0B | 3.7B | 3.7B | 2.6B |
Basic EPS | — | 6.0 | 6.0 | 4.3 |
Diluted EPS | — | 6.0 | 6.0 | 4.3 |
Basic average shares | — | 608.0M | 608.0M | 606.0M |
Diluted average shares | — | 608.0M | 608.0M | 606.0M |
EBITDA | 4.1B | 4.8B | 5.4B | 3.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | -3.5M | -6.3M | -8.6M | -12.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |